<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335088">
  <stage>Registered</stage>
  <submitdate>26/01/2010</submitdate>
  <approvaldate>9/03/2010</approvaldate>
  <actrnumber>ACTRN12610000198022</actrnumber>
  <trial_identification>
    <studytitle>Cannabis and Stroke Study (CASS): A comparison of positive drug screens for cannabis and amphetamines in stroke versus nonstroke patients</studytitle>
    <scientifictitle>Study comparing the proportion of positive drug screens for cannabis and amphetamines in stroke and nonstroke patients aged between 45 and 55 years</scientifictitle>
    <utrn />
    <trialacronym>CASS</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <healthcondition>Drug use (cannabis and amphetamines)</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Nonstroke patients aged 45- 55 years will have urine drug screen performed for cannabis and amphetamines.  One urine sample drug screen at time of admisssion.  Duration of study two years</interventions>
    <comparator>Stroke patients aged 45 - 55 years from medical records 2009 to 2011</comparator>
    <control>Historical</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of positive urine screens for cannabis and amphetamines in stroke and nonstroke patients</outcome>
      <timepoint>one urine sample drug screen at time of admission</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>age 45- 55 years
admission under general medicine with diagnosis other than stroke and a urine sample taken as part of their care</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Stroke</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Alan Barber</primarysponsorname>
    <primarysponsoraddress>Department of Medicine
University of Auckland
Level 12, Support Building
Auckland City Hospital
2 Park Road
Grafton 
Auckland 1023</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Neurology Pool Fund</fundingname>
      <fundingaddress>Auckland City Hospital
2 Park Road
Grafton
Auckland 1023</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The hypothesis is that cannabis and amphetamine use can precipitate stroke.  The Aim is to compare the proportion of positive urine drug screens of a group of young stroke patients with a group of nonstroke patients</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>27/01/2010</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Heidi Pridmore</name>
      <address>Neurology Research Unit
Department of Medicine
Level 12, Support Building
Auckland City Hospital
2 Park Road
Grafton 
Auckland 1023</address>
      <phone>+64 9 9231660</phone>
      <fax />
      <email>h.pridmore@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Heidi Pridmore</name>
      <address>Neurology Research Unit
Department of Medicine
Level 12, Support Building
Auckland City Hospital 
2 Park Road 
Grafton, Auckland 1023</address>
      <phone>+64 9 9231660</phone>
      <fax />
      <email>h.pridmore@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Heidi Pridmore</name>
      <address>Neurology Research Unit
Department of Medicine
Level 12, Support Building
Auckland City Hospital
2 Park Road 
Grafton, Auckland 1023</address>
      <phone />
      <fax />
      <email />
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>